RAIR Thyroid Cancer Research

Here are the direct links to the February 2026 research and trials: https://pubmed.ncbi.nlm.nih.gov/41686811/ https://pubmed.ncbi.nlm.nih.gov/41708943 https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1720670/full https://pmc.ncbi.nlm.nih.gov/articles/PMC12876518/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12921828/ https://clinicaltrials.gov/study/NCT07419932 https://clinical...

Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer: A Potential Strategy for Systemic Therapy Deferral (2024) Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis The Role of Stereotactic Radiotherapy in Deferring the Need for Systemic Therapies in Patients with Progressive Oli...

Advances in Immunotherapy for Thyroid Malignancies: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1754058/full "Living Sentinel" Implant for Continuous Thyroid Monitoring: https://www.cmu.edu/news/stories/archives/2026/january/inside-cmus-push-to-transform-treatment-for-cancer-organ-failure-and-chronic-disease Fatty Acid Metabolism Drives Bone Metastasis: https://www.mda...

* Study identifies patients who would benefit from redifferentiation therapy for thyroid cancer https://www.mayoclinic.org/medical-professionals/endocrinology/news/study-identifies-patients-who-would-benefit-from-redifferentiation-therapy-for-thyroid-cancer/mac-20592451 * BRAF and MEK Inhibition Beyond Dabrafenib-Trametinib in Advanced Thyroid Cancer https://www.frontiersin.org/journals/endocrinol...